CHMP recommends approval of generic telmisartan/hydrochlorothiazide medicines for essential hypertension
Source: European Medicines Agency
Area: News
The Committee for Medicinal Products for Human Use (CHMP) has recommending that the following two generic medicines be approved for the treatment of essential hypertension:
. Actelsar HCT (40mg/12.5 mg, 80mg/12.5 mg and 80mg/25 mg tablets)
. Tolucombi (40mg/12.5 mg, 80mg/12.5 mg and 80mg/25 mg tablets)
The active substances of these medicines are telmisartan (angiotensin II receptor antagonist) and hydrochlorothiazide (thiazide diuretic). Both are generics of MicardisPlus, which has been authorised in the EU since April 2002. Studies have demonstrated the satisfactory quality of these products and their bioequivalence with the reference product MicardisPlus.
Source: NeLM - Cardiovascular Medicine - Category: Cardiology Source Type: news
More News: Cardiology | Cardiovascular | European Medicines Agency (EMA) | Heart | Hydrochlorothiazide | Hypertension | Study